Created at	Source	Raw Value	Validated value
Oct. 7, 2021, noon	usa	Number of participants with treatment-related adverse events as assessed by CTCAE V4.0;Pharmacokinetic parameters(AUC0-τ);Pharmacokinetic parameters(Cmax);The Maximum Tolerable Dose (MTD)	Number of participants with treatment-related adverse events as assessed by CTCAE V4.0;Pharmacokinetic parameters(AUC0-τ);Pharmacokinetic parameters(Cmax);The Maximum Tolerable Dose (MTD)
Feb. 25, 2021, 7:58 p.m.	usa	Number of participants with treatment-related adverse events as assessed by CTCAE V4.0;Pharmacokinetic parameters(AUC);Pharmacokinetic parameters(Cmax);The Maximum Tolerable Dose (MTD)	Number of participants with treatment-related adverse events as assessed by CTCAE V4.0;Pharmacokinetic parameters(AUC);Pharmacokinetic parameters(Cmax);The Maximum Tolerable Dose (MTD)